Teladoc Health Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Teladoc Health Inc trades at $5.54 (market cap $1.01B), while Vipshop Holdings Ltd - ADR trades at $12.71 (market cap $6.07B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 6× Teladoc Health Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.86% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.
| TDOC | VIPS | |
|---|---|---|
Market Cap | $1.01B | $6.07B |
Volume | 3,622,440 | 3,134,219 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.72 | $20.29 |
52-Week Low | $4.47 | $12.09 |
Typical Hold Time | 39 Days | 49 Days |
Enterprise Value | $1.27B | $2.90B |
Dividend Yield | — | 4.86% |
Signals from Pluang's Aura AI — not financial advice
Teladoc Health (TDOC) trades at $5.54, down 3.99% in the latest session, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with oversold conditions while fundamentals reveal a mixed picture - strong gross margins of 68.97% but persistent net losses. Recent management changes and legal investigations add uncertainty, though the company maintains solid cash flow from operations of $294.36 million.
TDOC presents a high-risk opportunity with significant upside potential given the $8.83 consensus price target, representing 59% upside. However, continued net losses, negative cash flow trends, and competitive pressures in telehealth create substantial execution risk. The stock's current valuation at 0.4x sales appears attractive if the company can achieve profitability.
Vipshop (VIPS) trades at $12.72, down 0.24% on the day, with a bullish overall technical signal. The stock appears undervalued with a P/E of 4.12 and P/S of 0.41, supported by strong profitability metrics including a 9.82% net income margin and 24.44% ROE. Recent Q2 2026 earnings missed expectations, with revenue of $105.92 billion in 2025 showing a slight decline, but net income remains robust at $7.24 billion. Analyst consensus is bullish with a $16.17 price target.
The outlook for VIPS is mixed; attractive valuation and strong cash flow generation offer upside potential, but recent earnings misses and a challenging consumer environment pose near-term risks. Investor sentiment is cautiously optimistic, with 53.57% of analysts rating it a buy, though growth stagnation remains a key concern.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →